Project Grant W81XWH1710682

Federal Cooperative Agreement Summary Florida Atlantic University received a no-cost extension cooperative agreement from the Naval Air Warfare Center (NAWC), a subordinate agency within the Department of the Navy's Office of Naval Research (ONR), under the Basic and Applied Scientific Research program (CFDA 12.300). The award, obligating $143,112, extends through March 31, 2026, and supports development of a Physically-Constrained CycleGAN Training Data Generator (PCGAN-TAG) designed to enhance...

This Project Grant award, titled "TARGETING LYSOSOMAL PATHWAYS TO IMPROVE HOST IMMUNITY POST CORONAVIRAL INFECTIONS," is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,572,933 award to the University of Pittsburgh is effective from January 1, 2025 through December 31, 2028. The objective of this research project is to investigate novel approaches for improving host immune responses following coronavirus...

Summary The Defense Health Agency awarded a $1,197,884 Project Grant to the University of California, San Diego under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with a completion date of August 14, 2028. The project, titled "Mechanism Dissection and Model Development of Human PD1 in Melanoma," supports biomedical research aimed at advancing medical solutions for Service Members and the American public through innovative investigation into...

This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...

Federal Project Grant Award Summary The Office of Naval Research (ONR) awarded Massachusetts Institute of Technology (MIT) a $1.5 million Project Grant effective June 1, 2026, through May 31, 2030, under the Basic and Applied Scientific Research program (CFDA 12.300). The award supports the EMERGE project, which focuses on evolving morphologies via embodiment of reconfigurable geometries—a research initiative with potential applications to naval operations and technology advancement. The funding...

Cooperative Agreement Summary: Manipulating Microwaves with Ensembles of Emitters Oak Ridge Associated Universities, Incorporated (ORAU) received a modification to its existing Cooperative Agreement funded by the Office of the Secretary of Defense under the Basic Scientific Research program (CFDA 12.431) for research on "Manipulating Microwaves with Ensembles of Emitters." The award modification, issued February 26, 2026, provides an incremental funding allocation of $36,045.80 to...

The Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division in Omaha, Nebraska, received a $2.0 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2025 through May 31, 2028. The award supports advanced biomedical research investigating the interrelationship between PINK1-PRKN pathway disruption and tauopathy in the...

Federal Grant Award Summary The National Science Foundation (NSF) Division of Biological Infrastructure awarded $1.0M to the Regents of the University of California at Riverside under the Biological Sciences program (CFDA 47.074) to develop and validate TIMECLIP (Time-Resolved Detection of Protein-RNA Interactions), an advanced biotechnology platform for mapping when protein-RNA interactions occur during an RNA molecule's lifetime. The three-year project (September 1, 2026 through August 31,...

This $489,065.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of North Carolina at Chapel Hill (UNC-CH) will fund research to develop potentiated chip variants as therapies for alleviating tau pathology and neurodegeneration. The award period runs from July 1, 2025 to June 30, 2028. UNC-CH, through its Office of Sponsored Research, will conduct this advanced biomedical research project, leveraging...

Summary of Federal Cooperative Agreement Award Duke University received a Cooperative Agreement award of $536,817 from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective August 11, 2025, with completion scheduled for February 28, 2026. The award funds research and development of ORP100S, a pharmacologically optimized thioredoxin (TRX) derivative designed to mitigate lethal radiation-induced injury. The project...